GO	[-15.83 -0.92]	[-0.92 -0.54]	[-0.54 -0.27]	[-0.27 -0.05]	[-0.05 0.00]	[0.00 0.13]	[0.13 0.37]	[0.37 0.58]	[0.58 0.85]	[0.85 1.84]	[1.84 26.66]
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	-0.543	6.040	8.532	4.727	-2.599	-0.707	-0.301	-1.143	-3.765	-6.693	-6.674
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	0.514	5.545	8.323	1.156	-3.253	-4.525	0.799	-0.302	-2.307	-2.746	-4.507
SCHUHMACHER_MYC_TARGETS_UP SCHUHMACHER_MYC_TARGETS_UP	5.780	7.686	0.724	0.724	-1.707	-2.363	-0.865	-1.707	-1.225	-3.319	-2.355
MOOTHA_VOXPHOS MOOTHA_VOXPHOS	1.297	6.884	2.312	1.943	-1.420	-3.610	-0.731	-0.731	-1.029	-3.610	-2.612
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	7.869	1.726	1.726	0.856	-0.458	-3.485	-0.958	-3.485	-1.336	-1.336	-1.329
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	-1.637	0.767	2.879	3.881	-2.359	-0.701	3.532	-2.359	-0.422	0.285	-6.381
DANG_MYC_TARGETS_UP DANG_MYC_TARGETS_UP	2.168	6.863	1.864	1.325	-2.734	-2.734	0.282	-1.369	-1.739	-1.063	-2.722
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	0.721	5.002	2.530	2.835	-4.350	-1.211	0.721	-1.487	-0.776	-1.807	-3.661
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	-0.399	4.551	3.486	1.765	-2.192	-0.659	1.321	-0.517	-1.837	-1.837	-5.726
BENPORATH_PROLIFERATION BENPORATH_PROLIFERATION	-2.728	2.116	0.903	3.449	-4.949	-0.904	1.325	1.103	0.725	-1.153	-4.034
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	-0.946	3.039	1.227	4.423	-5.559	-0.756	0.567	-1.426	1.036	-0.463	-4.020
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	-0.959	3.895	1.287	2.566	-3.072	0.261	1.085	0.590	-0.761	-1.784	-6.066
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	0.554	-2.256	-1.173	-1.832	-2.256	-1.474	-0.921	-0.402	0.884	2.702	8.512
VERHAAK_AML_WITH_NPM1_MUTATED_UP VERHAAK_AML_WITH_NPM1_MUTATED_UP	-0.432	-1.997	-0.560	-0.898	-0.898	-2.831	-0.898	-0.560	-0.327	7.134	4.991
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	-0.791	0.629	1.403	2.503	-3.527	-1.590	1.914	2.199	0.266	-1.011	-5.166
WINNEPENNINCKX_MELANOMA_METASTASIS_UP WINNEPENNINCKX_MELANOMA_METASTASIS_UP	-1.162	-0.420	1.005	3.162	-3.165	-0.923	1.430	1.671	1.671	-1.162	-5.478
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	-3.761	-1.274	1.813	1.074	-2.485	-0.996	3.097	1.545	1.813	-0.430	-3.048
BURTON_ADIPOGENESIS_5 BURTON_ADIPOGENESIS_5	3.447	4.305	0.936	1.417	-3.790	-0.613	-0.613	-2.351	-1.099	-0.829	-1.424
PUJANA_XPRSS_INT_NETWORK PUJANA_XPRSS_INT_NETWORK	-1.281	-0.813	0.722	3.244	-3.355	-1.281	2.594	0.722	1.507	0.336	-4.762
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	-0.415	-2.952	-2.952	-2.051	0.392	-0.545	-2.468	2.412	2.412	1.612	2.731
KIM_ALL_DISORDERS_DURATION_CORR_DN KIM_ALL_DISORDERS_DURATION_CORR_DN	1.404	2.538	3.988	1.656	-1.384	-2.145	-0.258	-0.851	-0.490	-3.226	-2.625
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	-1.403	-0.889	-0.889	-0.399	-3.102	-1.403	-1.403	0.691	1.046	8.085	1.493
BROWN_MYELOID_CELL_DEVELOPMENT_UP BROWN_MYELOID_CELL_DEVELOPMENT_UP	-1.556	-0.621	-0.356	-1.010	-2.774	-1.556	-0.261	-0.356	0.907	10.209	0.462
RAMALHO_STEMNESS_UP RAMALHO_STEMNESS_UP	-0.844	0.766	2.813	4.134	-2.217	-0.672	2.521	-0.844	-0.528	-1.860	-3.607
WANG_CLIM2_TARGETS_DN WANG_CLIM2_TARGETS_DN	-3.808	0.409	-0.293	2.685	-0.836	-0.293	6.481	-0.293	0.309	-1.572	-2.704
WU_CELL_MIGRATION WU_CELL_MIGRATION	-2.746	-1.925	-0.851	-1.062	0.399	-1.308	-1.594	0.301	1.156	3.620	5.572
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	-4.070	-2.094	-0.962	0.845	-1.747	-1.186	3.000	4.374	0.691	1.017	-0.602
XIE_ST_HSC_S1PR3_OE_UP XIE_ST_HSC_S1PR3_OE_UP	-0.572	-2.860	-0.442	-1.681	-0.728	-1.386	-0.442	-0.572	0.269	3.117	8.056
PODAR_RESPONSE_TO_ADAPHOSTIN_UP PODAR_RESPONSE_TO_ADAPHOSTIN_UP	-2.759	-1.173	-0.292	-0.921	-1.832	-0.712	0.421	0.310	0.554	10.197	-0.289
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	3.102	3.102	0.597	1.620	-0.431	-1.191	-0.729	-0.729	-1.948	-1.948	-1.943
FUJII_YBX1_TARGETS_DN FUJII_YBX1_TARGETS_DN	-3.032	0.309	0.962	1.559	-2.571	-0.389	3.200	1.559	0.405	-0.294	-4.857
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	-1.487	-0.903	-0.687	-1.487	-0.373	-1.487	-2.336	0.782	0.340	2.620	7.006
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	-2.510	-1.836	0.856	3.332	-0.958	-0.958	4.310	0.636	-0.301	-0.458	-2.502
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	-3.592	-1.837	-0.829	0.781	-2.597	-0.829	2.555	2.850	1.321	1.765	-1.019
LIAN_LIPA_TARGETS_3M LIAN_LIPA_TARGETS_3M	0.651	-1.783	-1.783	-2.654	-0.527	0.440	-2.654	0.906	0.440	1.928	3.315
IRITANI_MAD1_TARGETS_DN IRITANI_MAD1_TARGETS_DN	2.134	2.134	2.640	-0.228	-1.907	-0.411	-0.411	0.389	-1.907	-1.907	-1.901
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	-0.975	-1.512	-1.852	-2.715	0.364	-0.767	-1.512	0.364	2.111	4.112	3.051
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	-2.573	-1.254	0.788	2.713	-1.609	-0.538	3.080	2.045	0.331	-0.727	-3.215
LI_DCP2_BOUND_MRNA LI_DCP2_BOUND_MRNA	0.995	4.510	1.899	-0.522	-1.966	-1.053	0.995	-0.522	-1.448	-0.351	-3.641
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	0.328	-0.856	-1.086	-2.065	-2.512	-0.506	-1.086	-0.856	1.302	4.901	3.725
CROMER_TUMORIGENESIS_UP CROMER_TUMORIGENESIS_UP	-1.035	-1.571	-1.035	-0.668	0.564	-0.668	-2.405	-1.035	0.814	2.275	5.682
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	-1.341	-2.001	-1.341	-1.341	-1.081	-0.676	-1.081	0.534	1.921	6.293	1.934
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	0.539	3.428	2.939	1.681	-1.363	-0.935	0.357	-0.935	-1.963	-1.963	-1.956
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	-0.744	-2.072	-1.635	-2.072	-1.277	-0.400	-0.552	0.768	0.967	7.204	1.200
KAAB_FAILED_HEART_ATRIUM_DN KAAB_FAILED_HEART_ATRIUM_DN	1.351	3.132	2.459	-0.682	-1.781	-0.275	0.923	-1.781	-0.515	-0.381	-4.894
RASHI_RESPONSE_TO_IONIZING_RADIATION_2 RASHI_RESPONSE_TO_IONIZING_RADIATION_2	-0.963	-2.043	-0.273	-0.273	-5.192	-0.727	1.746	0.458	-0.538	2.045	3.096
LINDSTEDT_DENDRITIC_CELL_MATURATION_B LINDSTEDT_DENDRITIC_CELL_MATURATION_B	-2.031	-0.472	-0.472	-1.259	-2.031	-0.782	1.137	1.512	-0.472	6.149	-0.469
PUJANA_BRCA_CENTERED_NETWORK PUJANA_BRCA_CENTERED_NETWORK	-0.829	-0.443	0.936	3.050	-2.982	-0.613	1.417	0.561	1.163	-0.443	-4.886
WHITFIELD_CELL_CYCLE_S WHITFIELD_CELL_CYCLE_S	-0.904	-0.528	0.433	1.325	-3.326	-0.904	4.643	0.903	0.725	0.319	-4.034
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	-2.613	-0.508	-0.508	1.244	-2.613	-1.181	-0.315	-0.786	0.288	1.982	4.506
HOELZEL_NF1_TARGETS_UP HOELZEL_NF1_TARGETS_UP	0.693	-2.485	-2.007	-0.311	-2.485	-0.767	0.291	-0.580	0.403	1.813	6.109
KONDO_PROSTATE_CANCER_WITH_H3K27ME3 KONDO_PROSTATE_CANCER_WITH_H3K27ME3	-1.528	-2.192	-1.260	-1.260	1.765	0.944	-3.061	0.301	0.635	0.781	4.960
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	-5.053	-0.334	-0.437	-0.437	-3.717	0.358	3.652	1.234	0.270	1.439	0.363
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	-0.663	-0.663	-0.663	-0.663	6.742	1.939	-0.663	-0.663	-0.663	-0.663	-0.246
HOLLERN_EMT_BREAST_TUMOR_DN HOLLERN_EMT_BREAST_TUMOR_DN	0.515	-1.928	-0.661	-1.508	-0.885	-1.928	-0.661	0.515	-0.661	2.901	6.048
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	-0.691	-0.691	-1.868	-0.981	-1.868	-0.981	0.289	-0.313	0.289	7.750	1.693
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN	-1.659	-3.345	0.277	0.606	-1.659	0.914	3.489	2.258	0.606	0.370	-2.817
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	-0.752	-0.581	0.630	1.379	-3.228	-1.201	2.437	2.145	1.870	-1.490	-2.673
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4 PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	-2.040	-0.465	-1.567	-0.651	-0.889	-0.323	-1.190	-0.651	0.280	4.512	5.019
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	-1.327	-1.949	-1.615	-0.687	-1.615	-0.687	0.633	-0.536	0.633	4.295	4.318
JISON_SICKLE_CELL_DISEASE_DN JISON_SICKLE_CELL_DISEASE_DN	-2.021	1.074	1.962	3.117	-2.411	-0.572	1.074	1.270	-0.442	-2.411	-2.008
PECE_MAMMARY_STEM_CELL_UP PECE_MAMMARY_STEM_CELL_UP	1.120	7.799	0.565	0.426	-1.953	-1.953	-0.292	-0.407	-1.231	-0.959	-0.952
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	0.578	-3.194	-0.797	-2.253	-0.797	-0.355	-0.541	-0.797	1.350	3.831	2.055
BURTON_ADIPOGENESIS_6 BURTON_ADIPOGENESIS_6	0.405	3.871	2.042	1.343	-2.571	-2.167	-0.389	-3.032	0.519	-1.011	0.313
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	-2.395	1.635	1.379	0.580	-2.962	-0.283	1.144	1.635	0.745	-0.940	-3.640
DANG_REGULATED_BY_MYC_UP DANG_REGULATED_BY_MYC_UP	0.560	5.189	0.790	1.375	-1.927	-0.390	-0.240	-0.606	-1.332	-2.820	-0.905
MORI_IMMATURE_B_LYMPHOCYTE_DN MORI_IMMATURE_B_LYMPHOCYTE_DN	-2.065	0.504	1.168	0.349	-2.065	-2.770	1.455	1.772	0.914	0.914	-2.761
ONDER_CDH1_TARGETS_3_DN ONDER_CDH1_TARGETS_3_DN	-0.434	-1.606	-1.064	-1.606	1.075	0.346	-1.064	0.541	-2.446	2.213	3.729
HOLLERN_SQUAMOUS_BREAST_TUMOR HOLLERN_SQUAMOUS_BREAST_TUMOR	0.402	-2.440	-2.026	-2.026	3.413	1.891	-1.362	-0.877	0.301	0.402	2.464
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	-0.541	-0.712	-0.921	1.081	-2.256	-0.921	0.708	-2.759	0.310	6.403	0.714
WELCSH_BRCA1_TARGETS_DN WELCSH_BRCA1_TARGETS_DN	1.516	4.210	1.272	1.051	-1.632	0.283	-0.320	-0.594	-1.296	-2.034	-3.080
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	-2.341	-0.975	1.457	-0.320	-1.234	-0.759	2.581	1.226	1.016	1.226	-4.179
TAVOR_CEBPA_TARGETS_UP TAVOR_CEBPA_TARGETS_UP	-2.156	-0.316	-1.362	0.286	-1.362	-1.362	-0.535	-0.316	0.720	5.736	1.371
GERY_CEBP_TARGETS GERY_CEBP_TARGETS	-1.084	-0.461	-0.625	0.273	-2.766	-2.218	-0.461	-0.625	1.067	5.282	2.143
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	-0.652	2.538	1.930	0.777	-3.226	-0.851	2.224	-0.851	-0.490	0.348	-3.213
ELVIDGE_HYPOXIA_DN ELVIDGE_HYPOXIA_DN	1.325	4.643	1.325	1.325	-1.153	-0.528	0.319	-1.452	-1.452	-1.807	-2.217
LIAN_LIPA_TARGETS_6M LIAN_LIPA_TARGETS_6M	0.353	-0.865	-2.363	-3.319	-0.596	-0.255	-1.225	0.965	0.724	2.282	2.705
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	-0.406	-1.363	-1.363	-2.862	1.681	0.539	-1.363	0.357	-0.935	2.484	2.495
RIGGI_EWING_SARCOMA_PROGENITOR_DN RIGGI_EWING_SARCOMA_PROGENITOR_DN	-0.659	-1.528	-0.829	-1.528	-0.659	-1.837	-1.528	0.781	2.555	2.012	3.848
HUANG_GATA2_TARGETS_UP HUANG_GATA2_TARGETS_UP	-1.883	-1.520	0.675	0.845	-2.821	-0.567	0.675	-0.743	-0.424	6.259	0.403
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP	-0.528	-0.697	1.103	-0.528	-4.049	-2.228	1.832	-0.528	0.319	4.227	0.323
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	1.730	1.730	2.330	1.730	-2.306	-0.499	0.627	-1.463	-1.845	-1.146	-1.836
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	-0.489	-0.301	-0.489	-1.152	-1.712	-0.301	-2.571	-0.762	0.970	4.590	2.046
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	-0.451	-2.009	-1.540	-2.009	0.290	-0.451	-2.009	0.976	1.220	4.112	1.500
WHITFIELD_CELL_CYCLE_G2_M WHITFIELD_CELL_CYCLE_G2_M	-1.095	-1.612	0.270	1.439	-3.177	-0.712	1.660	2.421	0.875	1.234	-2.691
RICKMAN_HEAD_AND_NECK_CANCER_C RICKMAN_HEAD_AND_NECK_CANCER_C	0.311	-1.055	-1.787	-2.288	0.983	-0.291	-2.913	-0.418	1.479	1.218	3.576
SERVITJA_ISLET_HNF1A_TARGETS_UP SERVITJA_ISLET_HNF1A_TARGETS_UP	1.055	-0.648	-1.301	-2.358	-0.277	-1.045	-1.951	0.706	-0.829	2.557	4.315
MEISSNER_NPC_HCP_WITH_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K27ME3	-0.842	-0.842	-1.675	-0.577	5.881	0.367	-1.198	-0.577	0.994	-1.675	1.604
VILIMAS_NOTCH1_TARGETS_UP VILIMAS_NOTCH1_TARGETS_UP	-1.328	-2.114	-0.837	0.301	-0.513	-0.513	-0.513	-0.513	-0.513	2.767	5.186
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	-0.272	1.821	5.288	-0.704	-0.704	-0.704	-0.704	-0.704	-0.704	0.332	-0.702
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	0.806	-0.326	-2.584	-3.568	0.806	1.052	-2.584	0.806	0.595	0.595	1.059
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2 ANDERSEN_CHOLANGIOCARCINOMA_CLASS2	-1.424	-4.246	-1.737	0.485	-0.327	0.276	-0.926	0.372	1.559	2.639	2.078
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	-1.296	-0.784	0.852	0.283	-3.093	-2.034	3.418	-0.442	0.283	3.051	-0.317
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	1.180	3.588	1.565	0.571	-0.755	-1.225	-0.256	-0.451	-0.755	-1.990	-1.984
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	-0.283	-0.940	-1.535	-2.395	1.144	-0.539	-2.962	0.580	1.379	0.745	3.640
GROSS_HYPOXIA_VIA_HIF1A_UP GROSS_HYPOXIA_VIA_HIF1A_UP	-0.355	5.483	0.798	1.350	-1.612	-0.797	0.798	-1.144	-1.612	-0.797	-1.139
PUJANA_BREAST_CANCER_LIT_INT_NETWORK PUJANA_BREAST_CANCER_LIT_INT_NETWORK	-1.828	-1.029	2.760	1.136	-1.381	-0.250	1.702	1.405	-0.752	-0.250	-3.134
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	-0.775	2.096	1.087	2.501	-2.217	0.598	-0.341	0.412	-1.117	-0.523	-3.144
UDAYAKUMAR_MED1_TARGETS_UP UDAYAKUMAR_MED1_TARGETS_UP	0.330	1.666	0.595	4.504	-2.365	-0.703	0.595	-0.526	-0.274	-1.188	-2.917
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	-0.285	-2.863	-1.321	0.318	-0.662	-1.321	-0.510	-0.510	0.423	2.520	5.067
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	-0.865	-0.865	-0.865	-0.397	-2.363	-1.225	0.965	-0.255	0.353	6.390	0.524
VILLANUEVA_LIVER_CANCER_KRT19_UP VILLANUEVA_LIVER_CANCER_KRT19_UP	-2.101	-2.101	-0.327	2.953	-0.926	0.938	1.333	0.938	1.333	-0.732	-2.510
TIEN_INTESTINE_PROBIOTICS_6HR_UP TIEN_INTESTINE_PROBIOTICS_6HR_UP	-0.348	2.543	1.652	0.258	-2.239	-0.578	2.076	-0.578	-0.921	-0.348	-2.233
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	1.431	2.261	2.261	0.985	-1.706	-1.362	0.628	0.257	-1.362	-1.706	-2.106
KOBAYASHI_EGFR_SIGNALING_24HR_UP KOBAYASHI_EGFR_SIGNALING_24HR_UP	-0.553	-1.407	1.108	-2.432	-2.432	-0.771	-0.771	0.667	1.372	2.709	1.381
ALCALA_APOPTOSIS ALCALA_APOPTOSIS	-0.338	0.576	1.943	5.126	-2.621	-0.338	-0.338	-1.029	-0.731	-0.505	-1.413
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2 BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	-0.422	4.988	2.012	0.997	-0.961	-1.999	-0.422	-0.647	-0.647	-1.393	-0.643
LENAOUR_DENDRITIC_CELL_MATURATION_UP LENAOUR_DENDRITIC_CELL_MATURATION_UP	2.076	-0.291	0.593	-0.792	-1.055	-0.792	-2.288	-2.288	-0.582	2.412	2.425
MIKKELSEN_IPS_WITH_HCP_H3K27ME3 MIKKELSEN_IPS_WITH_HCP_H3K27ME3	0.334	-0.398	-1.434	-1.434	3.473	0.476	-1.888	-1.074	1.629	-1.434	1.956
CERVERA_SDHB_TARGETS_2 CERVERA_SDHB_TARGETS_2	0.322	-2.256	-1.358	-1.760	-0.281	-1.034	-0.405	-0.405	4.502	2.116	0.801
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	-1.093	-0.851	-1.093	-2.145	-0.652	-0.490	0.612	-0.490	-0.258	6.207	1.668
HINATA_NFKB_TARGETS_KERATINOCYTE_UP HINATA_NFKB_TARGETS_KERATINOCYTE_UP	-0.981	-1.364	-1.364	-1.868	0.435	-0.691	-0.473	0.289	0.289	4.755	2.427
GOLDRATH_HOMEOSTATIC_PROLIFERATION GOLDRATH_HOMEOSTATIC_PROLIFERATION	0.903	1.103	1.103	2.116	-2.728	-0.697	0.319	0.903	0.319	-1.807	-3.312
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	-1.899	-0.921	1.169	-0.274	-4.483	-0.384	1.948	0.954	0.954	1.169	-0.915
LIEN_BREAST_CARCINOMA_METAPLASTIC LIEN_BREAST_CARCINOMA_METAPLASTIC	-1.367	-0.733	-1.367	-0.733	-0.385	-0.385	-1.367	0.754	0.453	3.306	2.098
LEE_EARLY_T_LYMPHOCYTE_UP LEE_EARLY_T_LYMPHOCYTE_UP	-2.071	-2.071	-0.668	1.426	-1.595	-0.668	1.163	2.031	2.739	-0.334	-0.663
PYEON_HPV_POSITIVE_TUMORS_UP PYEON_HPV_POSITIVE_TUMORS_UP	-2.331	-0.714	-0.506	0.259	-0.714	-2.331	2.114	1.779	2.114	0.946	-1.322
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	3.806	3.392	0.545	-0.456	0.281	-1.120	-1.872	-1.457	-0.848	-1.120	0.284
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	-3.102	-0.354	0.577	0.577	-1.807	-0.776	2.530	0.884	1.065	1.264	-2.593
ZHANG_RESPONSE_TO_CANTHARIDIN_DN ZHANG_RESPONSE_TO_CANTHARIDIN_DN	1.416	3.079	1.096	1.416	-1.891	-0.885	-0.586	-1.891	0.238	-0.885	-1.296
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	-0.767	-0.996	-0.767	-0.580	-0.996	-1.274	-0.767	-0.767	0.872	5.140	2.761
ONDER_CDH1_SIGNALING_VIA_CTNNB1 ONDER_CDH1_SIGNALING_VIA_CTNNB1	-0.672	-0.958	0.451	-1.336	-0.458	-1.336	-2.510	-0.301	1.402	2.886	2.480
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	-1.160	-1.160	-1.160	1.962	-1.160	-0.280	3.235	-0.280	-0.280	0.978	-0.577
SABATES_COLORECTAL_ADENOMA_UP SABATES_COLORECTAL_ADENOMA_UP	-2.007	-1.274	-1.608	-1.274	1.298	-0.311	-1.274	-0.311	1.545	2.414	2.116
WELCSH_BRCA1_TARGETS_UP WELCSH_BRCA1_TARGETS_UP	-1.373	-0.586	2.092	0.842	-3.779	-1.373	1.193	0.559	0.559	1.843	-1.363
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP	1.718	2.298	0.369	0.495	-4.754	0.369	0.495	-1.054	-1.682	0.643	-0.617
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	0.664	1.652	1.652	1.652	-0.578	-1.431	0.664	-0.348	-1.431	-1.431	-2.233
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	0.926	-1.045	-0.844	-0.528	-2.217	-0.310	-2.624	0.293	0.386	2.813	3.140
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	-0.714	-2.385	-0.327	-1.114	-0.714	-0.714	-0.432	-0.714	0.606	4.966	2.559
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	0.934	-2.976	-0.358	-0.823	-1.636	0.599	-1.636	-0.636	0.756	2.130	2.761
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	0.976	1.789	4.582	0.290	-1.167	-0.869	0.419	-0.869	-0.869	-1.167	-2.000
CHEBOTAEV_GR_TARGETS_UP CHEBOTAEV_GR_TARGETS_UP	0.243	-1.643	0.243	-2.290	-0.820	0.243	-1.171	-0.820	1.313	3.269	2.006
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	0.346	-0.691	-0.260	-1.606	-1.606	-2.446	0.346	-0.434	1.075	2.676	1.799
CERVERA_SDHB_TARGETS_1_UP CERVERA_SDHB_TARGETS_1_UP	0.254	-0.677	0.500	-1.533	-1.186	-2.477	-0.677	-0.354	0.364	2.853	3.650
LUCAS_HNF4A_TARGETS_UP LUCAS_HNF4A_TARGETS_UP	-2.405	0.564	-0.416	1.456	-0.668	-0.416	-2.405	0.564	-0.416	3.257	-0.245
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	-3.027	-0.301	-0.566	3.144	-1.980	-1.252	1.575	0.892	0.414	0.892	-0.745
RAMASWAMY_METASTASIS_UP RAMASWAMY_METASTASIS_UP	1.132	0.604	1.825	0.405	-2.737	-0.359	0.846	0.604	-0.359	-1.271	-2.729
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	0.551	-1.010	-1.249	-0.278	-3.162	-0.806	-0.491	-0.634	1.220	4.119	1.444
MILI_PSEUDOPODIA_CHEMOTAXIS_UP MILI_PSEUDOPODIA_CHEMOTAXIS_UP	-2.584	-1.005	0.806	1.331	-3.568	0.278	1.988	0.595	0.278	0.278	0.280
PRAMOONJAGO_SOX4_TARGETS_UP PRAMOONJAGO_SOX4_TARGETS_UP	-0.893	-0.332	-0.556	0.455	-2.197	-0.893	-0.893	-0.556	1.319	4.932	0.458
PHONG_TNF_TARGETS_UP PHONG_TNF_TARGETS_UP	-1.748	-2.613	-0.508	-0.315	-0.508	-0.786	-0.508	0.675	0.459	2.411	2.889
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	-0.817	-1.682	-1.682	-1.682	0.265	0.265	-1.054	0.814	1.007	1.007	4.535
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	-0.882	-1.097	2.879	0.932	-3.906	-1.097	0.767	1.769	0.620	-0.548	-0.542
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2 PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	-2.180	0.276	-0.327	0.276	-2.180	-1.091	0.276	-1.091	0.850	2.559	2.570
CROONQUIST_IL6_DEPRIVATION_DN CROONQUIST_IL6_DEPRIVATION_DN	-1.227	-1.227	0.816	1.318	-0.897	-1.650	1.942	0.816	0.441	1.318	-2.910
KONG_E2F3_TARGETS KONG_E2F3_TARGETS	-1.278	-1.278	0.771	-0.476	-0.940	-0.476	3.854	0.771	0.997	0.575	-2.984
BORCZUK_MALIGNANT_MESOTHELIOMA_DN BORCZUK_MALIGNANT_MESOTHELIOMA_DN	-0.438	-0.438	-2.568	-1.143	0.301	-3.334	0.783	1.249	0.432	1.827	1.533
RHODES_UNDIFFERENTIATED_CANCER RHODES_UNDIFFERENTIATED_CANCER	-0.252	0.763	4.503	0.357	-1.363	-1.363	0.539	-0.406	-0.252	-0.252	-2.854
CROONQUIST_NRAS_SIGNALING_DN CROONQUIST_NRAS_SIGNALING_DN	-1.393	-0.647	1.636	0.519	-0.422	-1.999	2.425	1.297	-0.961	0.737	-1.992
MALONEY_RESPONSE_TO_17AAG_DN MALONEY_RESPONSE_TO_17AAG_DN	1.350	1.055	2.444	1.350	-0.797	-1.144	0.578	-0.541	-1.144	-1.612	-2.245
LIANG_SILENCED_BY_METHYLATION_2 LIANG_SILENCED_BY_METHYLATION_2	-1.606	-1.064	-1.606	-0.434	0.541	-0.691	-0.434	-0.260	-0.434	2.213	4.305
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	-0.914	-0.442	-0.442	-0.728	-3.376	-1.132	0.468	0.360	0.360	1.962	4.172
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	1.577	2.092	2.092	-0.385	-1.367	0.231	-0.385	-0.385	-1.367	-0.733	-1.364
BOYLAN_MULTIPLE_MYELOMA_C_D_UP BOYLAN_MULTIPLE_MYELOMA_C_D_UP	0.551	1.097	0.710	2.140	-3.725	0.551	-0.418	-0.418	-1.980	1.097	-1.574
GRABARCZYK_BCL11B_TARGETS_UP GRABARCZYK_BCL11B_TARGETS_UP	-1.739	0.339	1.516	-0.412	-1.739	-1.253	-0.266	2.635	0.339	1.856	-1.732
KARLSSON_TGFB1_TARGETS_UP KARLSSON_TGFB1_TARGETS_UP	0.828	3.577	0.644	1.037	-3.157	-0.694	-0.510	-0.924	-0.694	0.828	-1.550
TAKAO_RESPONSE_TO_UVB_RADIATION_UP TAKAO_RESPONSE_TO_UVB_RADIATION_UP	-0.338	2.312	3.596	0.576	-2.621	-1.029	0.267	-0.505	-0.731	0.267	-1.413
NAGASHIMA_NRG1_SIGNALING_UP NAGASHIMA_NRG1_SIGNALING_UP	-1.118	-0.893	-0.310	0.292	-2.051	-1.118	-0.545	1.612	-0.545	5.288	0.652
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	-1.355	0.524	1.164	0.524	-1.355	0.707	2.071	0.524	0.249	-0.521	-4.139
GOZGIT_ESR1_TARGETS_UP GOZGIT_ESR1_TARGETS_UP	-0.712	-0.712	0.421	-1.832	-0.541	-0.541	-0.921	-0.541	-0.402	6.403	1.309
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	-0.347	0.355	0.260	2.992	-3.291	0.260	2.078	0.926	-0.608	-0.992	-1.866
JOHNSTONE_PARVB_TARGETS_2_UP JOHNSTONE_PARVB_TARGETS_2_UP	-1.093	-1.093	-0.258	0.348	-3.940	-1.093	1.404	0.777	0.777	2.872	-0.255
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	-1.260	-0.659	-0.659	-0.517	-2.597	0.301	-0.399	-0.517	0.507	5.332	1.547
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	-0.650	-1.824	-0.373	-1.824	-0.373	0.239	-0.373	-0.373	0.430	4.677	1.003
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	1.438	1.164	1.164	2.429	-1.798	-1.798	0.524	-1.006	-1.355	-1.355	0.251
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	-0.289	-2.473	-0.289	0.657	-0.934	-1.308	1.768	0.467	-0.934	3.880	-0.648
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP	0.419	-0.489	0.278	-1.005	-0.711	-2.584	-1.392	-0.489	0.806	4.155	1.339
VALK_AML_CLUSTER_5 VALK_AML_CLUSTER_5	-0.702	-1.326	-0.702	0.480	-1.326	-1.326	0.480	1.184	-0.363	3.426	0.482
GAVIN_FOXP3_TARGETS_CLUSTER_T7 GAVIN_FOXP3_TARGETS_CLUSTER_T7	-1.828	3.596	1.405	0.896	-2.399	-0.373	0.507	0.507	-0.752	-0.752	-1.023
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	-0.486	0.255	-1.439	-1.819	-0.486	-0.867	-1.819	1.492	1.245	0.490	3.856
LENAOUR_DENDRITIC_CELL_MATURATION_DN LENAOUR_DENDRITIC_CELL_MATURATION_DN	-1.084	0.273	-1.392	0.384	-2.218	-0.331	-2.218	2.130	1.067	2.452	0.523
RICKMAN_HEAD_AND_NECK_CANCER_A RICKMAN_HEAD_AND_NECK_CANCER_A	0.461	-0.411	-2.500	-1.918	0.629	0.629	-1.918	-0.585	1.309	0.461	3.013
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	-0.791	4.301	0.487	0.974	-1.960	-0.339	0.974	-0.459	-0.459	-0.339	-2.901
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	-0.581	-0.441	-0.328	-0.581	-1.828	-0.752	-0.752	-1.490	0.787	4.971	1.883
BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN	0.936	0.561	3.865	0.936	-2.982	-0.829	-0.312	-1.843	-0.829	0.291	-0.308
BURTON_ADIPOGENESIS_8 BURTON_ADIPOGENESIS_8	-1.198	-1.198	-0.383	-0.244	-3.277	-0.842	1.277	2.335	1.277	0.538	0.370
LIM_MAMMARY_LUMINAL_MATURE_DN LIM_MAMMARY_LUMINAL_MATURE_DN	0.441	-1.227	-0.447	-1.227	-1.227	-1.650	-0.897	0.816	0.612	1.052	4.496
SMITH_TERT_TARGETS_UP SMITH_TERT_TARGETS_UP	-0.490	-0.652	1.404	0.964	-2.637	-1.731	3.225	0.469	0.348	0.469	-1.721
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN	0.617	2.064	2.953	0.372	-3.580	-0.327	-0.926	0.768	-0.926	-0.732	-0.918
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	1.328	-0.483	-1.508	-1.508	0.376	-0.885	-1.508	-0.661	-0.343	1.886	3.707
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	0.389	1.559	0.783	1.338	-1.615	-0.310	2.052	0.502	-1.079	-2.775	-1.937
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP	-0.336	-0.942	-1.760	0.920	-1.445	-1.760	-0.747	0.269	2.309	3.240	0.610
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	-1.011	-2.167	-0.389	0.649	-3.561	0.519	2.589	-0.389	1.559	-0.294	0.805
BHATTACHARYA_EMBRYONIC_STEM_CELL BHATTACHARYA_EMBRYONIC_STEM_CELL	-0.458	0.301	2.081	2.468	-0.301	-0.958	1.402	-2.510	-1.836	-0.301	-0.667
MIKKELSEN_MEF_LCP_WITH_H3K27ME3 MIKKELSEN_MEF_LCP_WITH_H3K27ME3	0.328	-2.035	-0.986	-2.035	2.806	0.328	-1.424	0.712	0.499	-0.276	1.600
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	-1.998	-0.272	-0.272	-0.753	-1.675	-2.787	1.371	2.062	0.991	1.585	0.337
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	-0.672	-1.836	0.856	0.636	-3.485	0.451	1.726	1.112	0.856	-0.672	-0.667
GHANDHI_DIRECT_IRRADIATION_UP GHANDHI_DIRECT_IRRADIATION_UP	-0.601	-0.829	-1.949	-0.601	-0.424	-0.291	-0.601	-0.829	-0.291	4.246	2.959
AKL_HTLV1_INFECTION_DN AKL_HTLV1_INFECTION_DN	-1.963	-1.363	-0.935	0.357	-0.935	0.763	-0.406	-0.252	-0.626	3.950	1.689
WANG_HCP_PROSTATE_CANCER WANG_HCP_PROSTATE_CANCER	-1.979	0.783	-0.617	-1.143	-0.617	0.301	-0.438	1.524	-1.979	3.726	0.598
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	-1.036	-1.036	1.149	1.658	-1.036	0.398	1.658	0.398	-0.222	-1.036	-1.033
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	-0.265	-0.373	-1.872	-0.903	-1.872	-0.903	-0.373	-0.265	0.782	4.566	1.445
PARK_TRETINOIN_RESPONSE PARK_TRETINOIN_RESPONSE	0.166	-0.497	-0.497	-0.497	-0.497	-0.497	-0.497	0.166	0.524	5.787	-0.496
WINZEN_DEGRADED_VIA_KHSRP WINZEN_DEGRADED_VIA_KHSRP	-1.006	-1.798	-1.355	0.249	-1.355	-0.521	-0.360	-0.360	1.740	2.813	2.082
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2 SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	-1.261	-2.304	0.587	-0.356	-2.304	-1.010	0.738	0.457	1.097	3.287	0.593
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	-1.127	-1.127	-0.572	-0.572	-0.812	-0.391	-1.534	-0.572	2.496	2.496	2.130
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	-1.077	-0.241	0.371	-0.520	-1.077	0.371	-0.241	-1.077	0.371	5.139	-0.518
YAGI_AML_FAB_MARKERS YAGI_AML_FAB_MARKERS	-0.844	0.496	-0.310	0.766	-3.090	-1.860	-1.045	0.926	0.386	3.444	0.629
HUANG_FOXA2_TARGETS_DN HUANG_FOXA2_TARGETS_DN	-0.893	-0.893	-1.575	-0.266	-0.500	-1.575	-0.266	0.584	1.721	2.780	0.587
RODRIGUES_DCC_TARGETS_DN RODRIGUES_DCC_TARGETS_DN	-0.645	-0.645	0.388	0.891	-3.867	-1.142	0.891	0.891	0.697	2.242	-1.135
RUIZ_TNC_TARGETS_UP RUIZ_TNC_TARGETS_UP	-2.012	-1.318	-0.260	-0.482	-2.976	0.347	0.463	0.934	0.347	3.080	1.142
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	-0.608	0.451	-0.262	-2.178	-1.487	-0.262	-0.776	-0.468	-0.354	1.065	5.442
WIERENGA_STAT5A_TARGETS_GROUP2 WIERENGA_STAT5A_TARGETS_GROUP2	-0.921	-0.348	-2.239	-0.578	0.258	-0.921	0.258	-0.921	2.076	3.053	0.668
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	-0.483	-1.508	0.262	-1.164	-0.885	-0.483	-0.661	0.262	0.376	6.550	0.519
EPPERT_PROGENITOR EPPERT_PROGENITOR	-0.959	1.120	1.880	0.426	-3.689	-0.407	1.120	0.565	-0.959	0.912	-1.550
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	-2.473	0.657	0.313	0.883	-2.473	-0.442	2.130	0.883	0.883	-0.442	-1.302
RADMACHER_AML_PROGNOSIS RADMACHER_AML_PROGNOSIS	0.657	0.657	-0.652	-1.308	-0.442	-2.473	0.467	-1.803	-0.289	2.130	2.140
WIERENGA_STAT5A_TARGETS_GROUP1 WIERENGA_STAT5A_TARGETS_GROUP1	-0.412	-0.292	-0.566	-0.292	-4.136	-1.299	0.578	0.578	-0.412	2.286	1.983
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	-0.614	3.537	-0.266	1.516	-2.400	-0.266	1.209	-0.614	-1.253	-0.412	-0.883
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	-1.741	-1.024	-0.336	3.591	-1.741	-0.336	0.749	-0.599	0.476	0.476	0.479
SEIDEN_ONCOGENESIS_BY_MET SEIDEN_ONCOGENESIS_BY_MET	-1.999	-0.364	1.231	0.376	-1.077	0.736	2.602	0.736	0.376	-0.771	-2.686
MIKKELSEN_IPS_ICP_WITH_H3K27ME3 MIKKELSEN_IPS_ICP_WITH_H3K27ME3	1.232	0.245	-2.280	-2.280	1.232	-0.600	-0.949	-0.365	0.637	0.637	1.238
WONG_PROTEASOME_GENE_MODULE WONG_PROTEASOME_GENE_MODULE	0.521	1.877	0.781	-0.492	-0.810	0.317	1.461	0.521	-0.810	-2.073	-2.067
WILENSKY_RESPONSE_TO_DARAPLADIB WILENSKY_RESPONSE_TO_DARAPLADIB	0.324	-1.160	0.324	-0.580	-1.160	-0.580	-0.280	-0.580	-0.280	5.629	0.325
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	-0.640	0.283	-1.243	-1.243	-1.243	-0.320	-0.320	-0.320	1.796	2.991	0.542
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	0.434	-0.580	4.008	0.892	-0.580	0.434	-0.580	-0.580	-0.580	-0.580	-0.578
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	1.330	1.560	0.601	0.260	-2.277	-0.608	3.332	-0.608	-1.241	-0.782	-1.232
TIAN_TNF_SIGNALING_VIA_NFKB TIAN_TNF_SIGNALING_VIA_NFKB	-1.077	-1.077	-1.077	-0.241	-0.241	0.371	0.371	-0.241	-1.077	3.507	1.092
COLLER_MYC_TARGETS_UP COLLER_MYC_TARGETS_UP	3.048	2.357	0.426	-0.204	-0.462	-0.994	-0.994	-0.994	-0.462	-0.462	-0.460
BURTON_ADIPOGENESIS_PEAK_AT_0HR BURTON_ADIPOGENESIS_PEAK_AT_0HR	0.938	0.459	0.288	-0.508	-1.748	-1.181	-1.181	-0.786	-0.508	4.491	0.680
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	-0.447	-1.227	0.612	1.615	-2.197	-0.897	1.615	-0.301	1.052	1.052	-2.189
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	-0.432	0.751	0.277	0.370	-1.997	-2.831	2.542	0.277	-0.327	2.258	-1.105
BURTON_ADIPOGENESIS_PEAK_AT_16HR BURTON_ADIPOGENESIS_PEAK_AT_16HR	-0.599	-0.336	0.269	0.476	-1.741	0.269	1.477	-1.024	0.269	2.987	-1.736
TIEN_INTESTINE_PROBIOTICS_6HR_DN TIEN_INTESTINE_PROBIOTICS_6HR_DN	-2.863	-0.385	-0.510	0.690	-1.976	-0.662	1.952	0.690	1.236	1.695	-1.055
LEE_LIVER_CANCER_ACOX1_UP LEE_LIVER_CANCER_ACOX1_UP	-1.819	0.262	-0.344	-0.835	-1.241	0.627	0.262	-1.241	-0.344	4.302	1.174
SONG_TARGETS_OF_IE86_CMV_PROTEIN SONG_TARGETS_OF_IE86_CMV_PROTEIN	-0.949	-0.600	2.973	0.637	-0.600	-0.365	2.015	0.416	-0.949	-0.365	-2.274
NAKAJIMA_MAST_CELL NAKAJIMA_MAST_CELL	-0.228	-1.158	-0.702	-0.411	-1.907	0.625	-0.702	-0.228	-0.411	0.920	4.446
SMITH_LIVER_CANCER SMITH_LIVER_CANCER	-1.990	-0.451	1.180	0.848	-1.225	-0.755	0.571	0.571	0.848	1.180	-1.984
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	-0.981	-0.981	-0.313	0.831	-1.868	0.831	3.736	0.435	0.615	-1.868	-0.470
OSADA_ASCL1_TARGETS_DN OSADA_ASCL1_TARGETS_DN	-0.994	-0.462	-0.994	-0.204	-0.994	-0.204	-0.994	0.426	0.772	3.813	0.428
VANHARANTA_UTERINE_FIBROID_DN VANHARANTA_UTERINE_FIBROID_DN	0.238	-1.302	-0.885	-0.885	-1.891	-0.374	0.581	0.388	0.818	4.691	-0.372
FISCHER_G1_S_CELL_CYCLE FISCHER_G1_S_CELL_CYCLE	-1.130	-0.458	0.559	0.842	-4.403	-1.130	2.092	0.559	1.009	0.692	-0.452
GENTILE_UV_RESPONSE_CLUSTER_D7 GENTILE_UV_RESPONSE_CLUSTER_D7	-0.860	1.332	3.503	-0.477	-1.533	-0.250	0.614	-0.250	-1.533	-0.250	-0.474
CROONQUIST_STROMAL_STIMULATION_UP CROONQUIST_STROMAL_STIMULATION_UP	0.233	-0.977	-0.382	-0.622	-0.622	-0.382	-1.501	-1.501	1.551	1.190	3.437
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	-0.582	-0.582	0.311	-0.418	-2.913	0.311	0.983	-0.291	-0.792	4.905	-0.414
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3	0.716	-0.765	-0.407	-1.409	0.427	-1.409	-0.765	0.716	3.191	-0.765	0.719
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	-0.622	0.612	0.233	-0.622	-1.501	-1.501	-0.977	0.233	0.233	4.598	0.881
SEKI_INFLAMMATORY_RESPONSE_LPS_UP SEKI_INFLAMMATORY_RESPONSE_LPS_UP	-0.577	-1.198	-1.198	-1.198	-0.842	0.367	-0.244	-0.577	0.538	1.277	4.742
DELPUECH_FOXO3_TARGETS_UP DELPUECH_FOXO3_TARGETS_UP	-0.835	-1.241	-0.546	-1.241	-0.546	-1.241	-0.344	1.168	0.627	4.302	0.631
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	0.721	-0.354	0.344	-0.354	-1.807	-0.608	-1.807	-0.354	-1.211	1.718	3.869
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	-2.031	-0.271	-0.782	0.814	-2.031	1.137	-0.472	-0.782	0.814	1.137	1.142
MISSIAGLIA_REGULATED_BY_METHYLATION_DN MISSIAGLIA_REGULATED_BY_METHYLATION_DN	-0.905	0.254	0.364	2.496	-1.186	-1.533	0.661	0.849	0.849	0.661	-3.110
IGARASHI_ATF4_TARGETS_DN IGARASHI_ATF4_TARGETS_DN	-0.336	0.398	0.398	0.749	-3.032	-1.739	0.971	-1.303	2.159	0.971	-0.487
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	-0.746	-0.746	-0.298	-0.298	-0.298	-0.746	-0.298	-0.746	-0.298	2.399	3.190
LEE_LIVER_CANCER_SURVIVAL_DN LEE_LIVER_CANCER_SURVIVAL_DN	-1.230	0.706	2.209	1.457	-3.132	0.335	0.564	-0.270	0.440	-0.270	-2.191
NAGASHIMA_EGF_SIGNALING_UP NAGASHIMA_EGF_SIGNALING_UP	-0.399	-0.399	-0.645	-0.399	-2.363	-0.645	-0.399	0.379	-0.399	4.493	1.156
EPPERT_LSC_R EPPERT_LSC_R	-0.599	1.928	1.083	1.083	-0.599	-1.741	-0.599	-0.599	1.083	0.269	-1.736
HAN_JNK_SINGALING_UP HAN_JNK_SINGALING_UP	-0.430	-1.450	-0.219	-0.796	-0.219	-1.450	-0.219	-0.430	1.449	3.740	-0.217
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	0.459	-0.786	5.097	0.288	-0.786	-0.315	-1.181	0.675	-1.748	0.288	-0.505
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	-0.828	-0.828	-1.492	-0.234	-1.492	0.380	0.380	-0.234	-0.234	3.619	0.988
SWEET_KRAS_TARGETS_UP SWEET_KRAS_TARGETS_UP	-0.289	-0.652	-1.803	-0.934	-1.308	-0.652	-0.442	-0.289	1.144	3.399	1.777
INGRAM_SHH_TARGETS_UP INGRAM_SHH_TARGETS_UP	-0.400	-0.400	-0.983	-2.072	-1.277	-0.282	0.594	0.768	2.327	2.668	-1.269
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	0.251	0.682	1.951	1.951	-1.649	-0.357	1.363	-0.357	-0.950	-1.261	-2.123
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP	-0.434	4.846	0.457	0.199	-0.434	0.199	-0.953	-0.953	-0.434	0.457	-0.950
JAIN_NFKB_SIGNALING JAIN_NFKB_SIGNALING	0.288	2.619	1.153	1.466	-2.144	0.288	-0.488	-0.732	-0.314	-0.488	-2.136
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	0.250	1.458	2.231	1.132	0.405	-1.271	0.250	-0.566	-0.860	-0.566	-2.729
BILBAN_B_CLL_LPL_DN BILBAN_B_CLL_LPL_DN	-0.336	-0.336	-0.336	0.749	-1.741	-1.741	1.477	-0.336	-0.599	2.987	-0.334
MISSIAGLIA_REGULATED_BY_METHYLATION_UP MISSIAGLIA_REGULATED_BY_METHYLATION_UP	-0.744	-0.552	-1.635	-0.282	-2.605	-0.400	0.321	-0.282	1.712	3.415	0.599
IKEDA_MIR30_TARGETS_UP IKEDA_MIR30_TARGETS_UP	-2.913	0.593	-0.291	-0.418	-1.383	-0.291	2.412	0.775	0.775	0.983	-1.779
LEE_LIVER_CANCER_HEPATOBLAST LEE_LIVER_CANCER_HEPATOBLAST	-0.663	-0.663	-0.663	-0.247	0.362	-0.663	-0.247	-0.663	-0.247	4.517	0.764
ISHIDA_E2F_TARGETS ISHIDA_E2F_TARGETS	-0.865	-0.865	0.286	-0.316	-1.362	0.286	3.220	0.720	0.286	1.017	-2.150
GAVIN_FOXP3_TARGETS_CLUSTER_P7 GAVIN_FOXP3_TARGETS_CLUSTER_P7	-1.151	-1.563	-0.404	-1.151	-0.589	-2.098	0.889	1.419	1.419	1.419	0.895
BASSO_CD40_SIGNALING_UP BASSO_CD40_SIGNALING_UP	-1.858	-0.771	-1.051	0.346	-1.051	-0.260	0.872	0.346	-0.553	4.953	0.350
LIU_COMMON_CANCER_GENES LIU_COMMON_CANCER_GENES	-1.211	1.928	0.440	0.440	-2.654	-0.329	1.546	0.440	-0.810	0.651	-1.206
FARMER_BREAST_CANCER_CLUSTER_4 FARMER_BREAST_CANCER_CLUSTER_4	-0.324	-0.787	1.057	-0.787	0.609	-0.787	-0.787	-0.324	-0.324	-0.324	3.865
WHITFIELD_CELL_CYCLE_G2 WHITFIELD_CELL_CYCLE_G2	-1.045	-1.601	0.434	1.481	-1.045	-1.045	1.259	1.259	1.983	-0.277	-1.939
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	-0.567	0.610	1.007	2.456	-0.567	-0.567	1.246	-0.281	-0.281	-1.034	-3.664
WHITFIELD_CELL_CYCLE_M_G1 WHITFIELD_CELL_CYCLE_M_G1	-1.254	0.610	1.218	0.610	-1.609	-0.963	3.878	-0.273	-0.388	-0.273	-1.601
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	-0.624	-0.624	-0.432	-1.621	-0.875	-0.290	-0.290	-1.201	0.456	4.061	1.995
WHITFIELD_CELL_CYCLE_LITERATURE WHITFIELD_CELL_CYCLE_LITERATURE	-0.650	-1.090	2.277	0.239	-1.090	0.239	-0.650	2.277	0.430	0.430	-1.819
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	-2.446	-0.434	-0.434	0.784	-0.434	-0.691	1.411	0.784	2.213	-0.260	-1.601
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	-0.753	-1.091	-0.327	-3.111	0.276	-0.506	-0.506	0.850	0.620	2.147	1.434
KUMAR_AUTOPHAGY_NETWORK KUMAR_AUTOPHAGY_NETWORK	-0.454	0.936	1.549	0.688	-1.455	-0.689	0.314	-0.689	0.314	1.549	-2.978
HUMMERICH_SKIN_CANCER_PROGRESSION_UP HUMMERICH_SKIN_CANCER_PROGRESSION_UP	0.557	-0.351	-0.751	-0.751	-2.658	-0.751	0.557	-0.522	-0.522	2.263	2.668
GOLDRATH_IMMUNE_MEMORY GOLDRATH_IMMUNE_MEMORY	0.440	-0.329	0.274	-0.810	-2.654	-1.783	0.440	0.651	0.651	2.808	-0.327
JIANG_TIP30_TARGETS_UP JIANG_TIP30_TARGETS_UP	-1.907	0.920	-0.411	-1.158	-1.158	0.389	1.271	-0.411	2.640	0.389	-0.699
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	-0.538	-1.477	2.214	0.376	-2.696	-1.077	0.967	1.528	0.539	-0.538	0.248
REN_BOUND_BY_E2F REN_BOUND_BY_E2F	-1.712	-0.489	2.474	1.284	-1.152	-0.301	1.640	-0.489	0.301	-0.301	-1.706
ROSS_AML_WITH_MLL_FUSIONS ROSS_AML_WITH_MLL_FUSIONS	-0.865	0.724	0.353	0.520	-2.363	-1.225	-0.596	0.353	0.724	3.608	-0.860
CHEBOTAEV_GR_TARGETS_DN CHEBOTAEV_GR_TARGETS_DN	-0.292	-0.412	-0.566	-1.299	-0.566	-0.412	-1.003	-1.299	0.749	0.945	5.109
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	-1.053	-1.448	-0.522	-1.053	-0.351	0.256	-1.966	1.899	0.759	1.899	1.271
BROCKE_APOPTOSIS_REVERSED_BY_IL6 BROCKE_APOPTOSIS_REVERSED_BY_IL6	-0.652	-0.652	-0.360	0.469	-2.145	-0.851	1.404	-0.490	0.469	4.397	-0.845
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	-1.367	0.231	0.453	-0.733	-1.367	0.754	1.577	-0.385	1.577	0.453	-1.364
LAIHO_COLORECTAL_CANCER_SERRATED_UP LAIHO_COLORECTAL_CANCER_SERRATED_UP	-1.760	-0.567	0.610	-0.281	-3.676	0.795	1.801	1.007	0.795	-0.405	-0.401
IVANOVA_HEMATOPOIESIS_STEM_CELL IVANOVA_HEMATOPOIESIS_STEM_CELL	-0.946	-0.463	-2.069	-0.353	-2.069	-0.596	1.227	1.661	0.446	2.731	-0.260
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	0.662	-1.572	0.409	-1.044	-0.660	-2.281	-1.044	0.662	0.815	0.987	3.014
GENTILE_RESPONSE_CLUSTER_D3 GENTILE_RESPONSE_CLUSTER_D3	-0.893	0.272	0.980	1.319	-0.893	-1.397	1.706	0.272	1.319	-1.397	-1.392
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	-1.271	-0.860	2.231	-0.860	-0.860	0.405	-0.566	-1.855	0.846	1.132	1.466
ZHU_CMV_8_HR_UP ZHU_CMV_8_HR_UP	0.501	-0.991	-1.699	-0.991	-0.574	-0.991	-0.318	0.783	0.501	3.082	0.787
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	-1.053	0.557	0.995	0.995	-1.053	-1.966	1.264	0.390	0.759	0.557	-2.649
CHUNG_BLISTER_CYTOTOXICITY_UP CHUNG_BLISTER_CYTOTOXICITY_UP	-0.396	1.914	1.635	0.580	-2.395	-1.535	1.379	-0.539	-0.719	0.580	-1.201
DURAND_STROMA_NS_UP DURAND_STROMA_NS_UP	-0.261	-1.010	-0.621	0.907	-2.774	-0.798	-1.010	-0.261	0.587	1.781	2.648
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	-1.158	-1.158	-1.158	-0.411	-0.228	-0.702	0.920	-0.228	-0.702	1.677	3.204
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP	1.647	0.923	0.301	0.731	-3.333	0.420	-1.687	-0.778	-0.778	1.382	0.304
BRUECKNER_TARGETS_OF_MIRLET7A3_DN BRUECKNER_TARGETS_OF_MIRLET7A3_DN	-1.117	-0.523	-0.341	-0.523	-0.523	-0.775	-0.523	-0.341	-0.775	1.724	5.014
HOSHIDA_LIVER_CANCER_SUBCLASS_S2 HOSHIDA_LIVER_CANCER_SUBCLASS_S2	-1.383	0.593	1.479	1.765	-2.288	-0.291	0.983	0.983	-0.418	-1.055	-1.375
LEE_NEURAL_CREST_STEM_CELL_UP LEE_NEURAL_CREST_STEM_CELL_UP	-0.515	-0.886	-0.275	-2.698	-0.275	-1.429	-0.682	1.126	0.582	2.151	1.876
HASINA_NOL7_TARGETS_UP HASINA_NOL7_TARGETS_UP	-0.538	-0.538	-0.176	-0.176	-0.538	-0.538	-0.176	-0.176	-0.176	5.408	-0.537
NUTT_GBM_VS_AO_GLIOMA_DN NUTT_GBM_VS_AO_GLIOMA_DN	0.920	2.134	1.677	-0.228	-0.702	-0.411	-0.228	0.389	-1.158	-1.158	-1.901
TSAI_RESPONSE_TO_IONIZING_RADIATION TSAI_RESPONSE_TO_IONIZING_RADIATION	-2.284	-0.939	-0.554	1.511	-0.939	-0.728	0.691	-0.939	0.410	2.998	0.872
ANDERSEN_LIVER_CANCER_KRT19_UP ANDERSEN_LIVER_CANCER_KRT19_UP	-0.765	3.191	0.216	1.512	-0.765	-0.765	-0.407	-0.765	0.216	0.716	-1.405
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	-2.197	3.135	0.980	0.980	-0.556	0.272	-0.893	0.272	-0.332	-0.556	-0.888
AFFAR_YY1_TARGETS_UP AFFAR_YY1_TARGETS_UP	-0.334	-1.335	-1.095	-0.712	0.463	-0.889	-0.562	-0.712	0.358	1.439	4.754
KIM_MYC_AMPLIFICATION_TARGETS_DN KIM_MYC_AMPLIFICATION_TARGETS_DN	-0.678	-1.278	-0.476	-0.476	-1.278	-0.476	1.859	-0.678	0.279	4.331	0.282
GEORGES_CELL_CYCLE_MIR192_TARGETS GEORGES_CELL_CYCLE_MIR192_TARGETS	-1.712	-1.712	0.301	0.970	-0.489	-0.301	2.037	-1.152	1.284	0.970	-0.758
RAY_ALZHEIMERS_DISEASE RAY_ALZHEIMERS_DISEASE	-0.176	-0.176	-0.538	-0.538	-0.538	-0.538	-0.538	-0.538	0.476	4.273	0.478
GERHOLD_ADIPOGENESIS_DN GERHOLD_ADIPOGENESIS_DN	-0.489	0.301	0.970	-0.489	-1.712	-1.152	-1.712	0.478	-0.301	2.949	0.976
SCHEIDEREIT_IKK_TARGETS SCHEIDEREIT_IKK_TARGETS	-0.704	0.332	-0.704	-0.272	-0.272	-0.704	3.361	0.706	0.706	-0.704	-0.702
KOBAYASHI_EGFR_SIGNALING_6HR_DN KOBAYASHI_EGFR_SIGNALING_6HR_DN	-0.746	-0.298	-0.746	-0.298	-0.746	-0.746	-0.746	0.304	1.128	1.713	1.717
PLASARI_NFIC_TARGETS_BASAL_UP PLASARI_NFIC_TARGETS_BASAL_UP	0.978	-0.580	-1.160	-0.580	-1.160	-0.580	-0.580	0.607	-0.280	0.607	3.244
GHANDHI_BYSTANDER_IRRADIATION_UP GHANDHI_BYSTANDER_IRRADIATION_UP	-0.672	-0.301	-1.336	-1.336	-0.301	0.301	-0.301	-1.836	1.112	2.886	1.410
BILD_CTNNB1_ONCOGENIC_SIGNATURE BILD_CTNNB1_ONCOGENIC_SIGNATURE	-2.290	-0.369	-0.369	-0.559	-1.171	0.381	2.813	1.638	0.381	0.558	-1.165
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	0.259	-0.714	-0.714	-0.348	-0.714	-0.348	-0.506	-0.984	-0.714	0.946	5.746
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	-0.556	-0.923	-0.310	-0.556	-0.923	-0.923	-0.923	-0.556	0.517	1.671	4.694
SANA_TNF_SIGNALING_UP SANA_TNF_SIGNALING_UP	-0.458	-1.336	-1.836	0.301	-0.672	-0.458	0.301	-0.958	0.636	2.468	2.480
DER_IFN_BETA_RESPONSE_UP DER_IFN_BETA_RESPONSE_UP	-1.434	-0.790	0.334	0.849	-2.466	-0.270	1.945	1.080	0.334	1.080	-1.426
GU_PDEF_TARGETS_DN GU_PDEF_TARGETS_DN	-1.658	-0.549	-0.300	-0.300	1.594	-1.658	-0.549	0.527	-0.549	1.176	1.600
GYORFFY_MITOXANTRONE_RESISTANCE GYORFFY_MITOXANTRONE_RESISTANCE	-0.796	-1.450	-0.796	-0.219	-0.430	-1.450	1.933	1.449	0.403	1.030	-0.217
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	-0.961	-0.961	-1.393	1.297	-1.999	0.519	1.636	0.737	0.519	0.997	-0.956
BROWNE_HCMV_INFECTION_12HR_UP BROWNE_HCMV_INFECTION_12HR_UP	-1.676	-0.720	1.082	1.082	-2.163	-0.522	2.971	0.496	0.355	-0.720	-0.365
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	-0.416	-1.035	1.456	-0.668	-0.668	-1.571	0.362	0.564	-0.416	3.806	-0.664
WOO_LIVER_CANCER_RECURRENCE_UP WOO_LIVER_CANCER_RECURRENCE_UP	-1.120	0.447	0.447	-0.601	-1.487	-0.829	-0.601	-0.424	-0.601	1.866	3.805
XIE_LT_HSC_S1PR3_OE_UP XIE_LT_HSC_S1PR3_OE_UP	-1.202	-0.610	-0.610	0.302	-1.202	-1.202	0.302	0.572	0.572	1.877	1.369
NEWMAN_ERCC6_TARGETS_DN NEWMAN_ERCC6_TARGETS_DN	-0.925	-0.525	-0.925	-1.616	0.320	0.320	-0.525	0.858	-0.283	0.320	3.942
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	1.021	1.492	-2.831	-2.276	-1.125	0.255	0.820	0.820	0.255	0.255	0.649
BROWNE_HCMV_INFECTION_2HR_UP BROWNE_HCMV_INFECTION_2HR_UP	0.302	-0.300	-0.958	-0.958	-0.958	-0.549	-0.958	0.302	-0.300	1.594	3.824
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	0.646	-0.453	-0.828	0.380	-1.492	-0.828	0.984	0.380	0.380	2.389	-1.488
WEINMANN_ADAPTATION_TO_HYPOXIA_DN WEINMANN_ADAPTATION_TO_HYPOXIA_DN	-0.525	0.320	0.555	-0.525	0.320	-0.925	-1.616	-1.616	0.555	1.656	1.662
FARMER_BREAST_CANCER_CLUSTER_5 FARMER_BREAST_CANCER_CLUSTER_5	-0.324	0.279	0.609	2.269	-0.787	-0.787	0.609	-0.787	-0.787	1.057	-0.785
LEIN_CHOROID_PLEXUS_MARKERS LEIN_CHOROID_PLEXUS_MARKERS	-0.291	-0.601	-0.601	-1.949	-1.949	-0.601	0.804	0.312	0.312	2.199	2.211
KAUFFMANN_MELANOMA_RELAPSE_UP KAUFFMANN_MELANOMA_RELAPSE_UP	-0.738	-0.738	0.315	1.689	-1.122	-0.470	1.689	0.728	0.728	-0.287	-2.522
ZHAN_MULTIPLE_MYELOMA_PR_UP ZHAN_MULTIPLE_MYELOMA_PR_UP	-1.907	-0.702	0.389	0.625	-0.702	-0.702	1.271	3.193	-0.228	-0.411	-0.699
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	-1.055	0.439	1.479	2.076	-2.288	-0.582	0.439	0.439	0.983	-0.582	-1.779
ROSS_LEUKEMIA_WITH_MLL_FUSIONS ROSS_LEUKEMIA_WITH_MLL_FUSIONS	-1.707	0.520	0.353	0.353	-2.363	-0.865	-0.397	-0.255	-0.255	3.136	0.971
HATADA_METHYLATED_IN_LUNG_CANCER_DN HATADA_METHYLATED_IN_LUNG_CANCER_DN	1.933	-0.219	-1.450	-1.450	-0.430	0.680	-0.430	-0.796	-0.430	0.403	1.939
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	-0.893	-1.397	-0.893	-0.332	-1.397	0.691	1.706	0.455	2.139	0.691	-0.888
MOHANKUMAR_HOXA1_TARGETS_DN MOHANKUMAR_HOXA1_TARGETS_DN	0.660	-0.877	-0.689	-1.362	0.522	-1.669	-1.100	0.402	0.301	0.995	3.789
LEONARD_HYPOXIA LEONARD_HYPOXIA	1.534	0.501	-0.991	0.285	-0.574	-1.699	-0.574	-0.991	1.534	1.534	-0.571
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	-0.411	0.827	0.461	2.998	-2.500	-1.460	0.323	0.323	-0.411	0.827	-1.091
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN	-1.284	-0.341	0.264	-1.284	-1.284	-0.671	0.264	1.241	0.509	1.241	1.246
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	0.404	-1.420	-0.505	-1.029	0.782	-0.505	-1.933	-0.505	2.712	0.404	1.613
PRAMOONJAGO_SOX4_TARGETS_DN PRAMOONJAGO_SOX4_TARGETS_DN	1.137	1.137	2.929	-0.472	-1.259	-0.782	-0.782	0.546	-0.271	-1.259	-0.779
SENESE_HDAC2_TARGETS_DN SENESE_HDAC2_TARGETS_DN	0.840	0.264	-2.247	-1.792	0.264	-0.641	-1.416	0.372	1.796	1.044	1.280
GAVIN_FOXP3_TARGETS_CLUSTER_P4 GAVIN_FOXP3_TARGETS_CLUSTER_P4	0.507	-0.373	-0.537	-0.250	-1.381	-2.399	0.359	-0.537	-0.373	3.596	1.143
JIANG_HYPOXIA_CANCER JIANG_HYPOXIA_CANCER	-0.416	0.814	1.456	1.112	-1.035	0.362	-0.416	0.362	0.814	-1.571	-2.398
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	-1.406	0.943	-1.756	1.377	-1.406	-0.267	3.178	-0.267	-0.267	-0.267	-0.661
VERRECCHIA_RESPONSE_TO_TGFB1_C4 VERRECCHIA_RESPONSE_TO_TGFB1_C4	-0.456	0.187	-0.456	0.187	-0.456	-0.456	1.875	-0.456	-0.456	-0.456	2.753
SUNG_METASTASIS_STROMA_UP SUNG_METASTASIS_STROMA_UP	-0.668	-0.909	0.542	-0.334	-1.214	-1.214	-0.668	-0.334	1.715	3.982	-0.331
MOOTHA_TCA MOOTHA_TCA	0.762	2.696	1.292	-0.247	-0.247	-0.663	-0.247	-0.663	-0.663	-0.663	-0.661
SU_TESTIS SU_TESTIS	-2.363	-0.865	-0.397	1.555	-1.707	1.243	0.520	1.555	-0.596	-0.255	0.356
NELSON_RESPONSE_TO_ANDROGEN_DN NELSON_RESPONSE_TO_ANDROGEN_DN	0.332	2.541	-0.272	-0.704	-0.704	-0.704	-0.704	1.206	-0.272	0.706	-0.702
BURTON_ADIPOGENESIS_3 BURTON_ADIPOGENESIS_3	-1.407	-0.385	-0.553	0.667	-1.407	-0.385	2.334	0.492	0.346	1.986	-1.850
BROWN_MYELOID_CELL_DEVELOPMENT_DN BROWN_MYELOID_CELL_DEVELOPMENT_DN	3.362	1.679	0.578	-0.412	-1.661	-0.761	0.311	-1.003	-0.566	0.432	-1.292
BOYLAN_MULTIPLE_MYELOMA_D_DN BOYLAN_MULTIPLE_MYELOMA_D_DN	-1.253	-0.888	0.502	0.502	-1.253	-1.253	-0.412	0.502	-0.412	4.031	0.706
BASSO_B_LYMPHOCYTE_NETWORK BASSO_B_LYMPHOCYTE_NETWORK	0.597	2.498	1.626	0.457	-2.667	-0.371	-0.267	-0.503	-0.667	0.338	-1.746
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN	-0.870	0.236	0.236	-0.378	-0.870	-0.870	-0.378	-0.870	1.436	2.036	0.933
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	0.551	-0.751	-0.418	-2.455	3.913	-0.751	-0.751	-0.301	-0.418	0.414	1.105
LINDSTEDT_DENDRITIC_CELL_MATURATION_A LINDSTEDT_DENDRITIC_CELL_MATURATION_A	-0.762	-0.762	-0.762	-0.301	-0.301	-0.489	-0.301	-1.152	-0.489	2.037	4.022
KIM_WT1_TARGETS_8HR_UP KIM_WT1_TARGETS_8HR_UP	0.345	-2.304	-0.356	-0.356	-1.556	-0.798	1.781	1.097	0.345	2.330	-0.791
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	-0.578	-0.348	0.664	0.435	-2.239	0.258	0.435	0.435	-1.431	3.053	-0.575
DARWICHE_PAPILLOMA_RISK_HIGH_UP DARWICHE_PAPILLOMA_RISK_HIGH_UP	-2.256	3.042	0.421	1.081	-0.921	0.554	0.554	-1.832	-0.402	-0.541	0.313
HOWLIN_PUBERTAL_MAMMARY_GLAND HOWLIN_PUBERTAL_MAMMARY_GLAND	-0.885	-0.586	-1.891	-0.586	-1.302	2.174	-0.586	0.388	0.581	1.776	0.822
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53 AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	-1.190	-0.323	-1.190	0.741	-2.040	-0.323	0.405	-0.889	0.952	3.185	0.564
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	0.712	1.259	1.592	0.499	-1.424	0.499	0.712	-0.276	-0.986	-1.424	-2.028
BROWNE_HCMV_INFECTION_18HR_UP BROWNE_HCMV_INFECTION_18HR_UP	-1.100	-1.100	0.818	0.522	-1.100	-0.877	3.413	0.818	0.301	0.660	-1.658
AIGNER_ZEB1_TARGETS AIGNER_ZEB1_TARGETS	-0.796	-0.430	-0.796	-0.430	-0.219	-1.450	0.403	0.403	-0.430	0.403	4.464
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	-1.167	1.220	1.220	1.789	-2.603	-0.451	-0.451	0.576	-0.869	0.762	-0.863
NADLER_OBESITY_UP NADLER_OBESITY_UP	-0.274	-0.715	-0.274	-0.715	-1.642	-0.715	0.330	0.756	1.039	3.629	-1.088
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	-0.427	-0.326	-0.326	-0.873	-3.148	-0.699	-0.699	2.182	1.926	0.473	0.901
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	-0.406	2.939	1.336	0.539	-0.626	-0.406	-0.406	-0.626	-1.363	0.763	-1.956
HECKER_IFNB1_TARGETS HECKER_IFNB1_TARGETS	0.324	-1.592	-0.418	-1.592	-0.279	-0.418	-0.606	-0.418	-0.279	1.692	3.674
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	1.029	0.539	0.763	0.357	-2.862	-1.963	0.763	-0.935	0.357	0.539	0.360
KASLER_HDAC7_TARGETS_1_UP KASLER_HDAC7_TARGETS_1_UP	-0.621	0.998	2.102	1.610	-2.517	-0.978	0.998	-0.484	-0.484	-0.278	-1.195
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	-0.746	-0.746	-0.298	-0.746	0.304	-0.746	0.304	0.304	0.304	4.058	-0.297
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	-0.473	0.372	1.271	1.796	-0.641	-1.104	-0.342	-0.342	-1.792	2.411	-1.407
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	-0.478	-0.638	-0.638	-0.638	-2.117	0.257	0.257	0.257	0.795	4.885	-0.346
YAMAZAKI_TCEB3_TARGETS_UP YAMAZAKI_TCEB3_TARGETS_UP	-0.992	0.926	-0.464	-0.992	-3.936	0.355	0.926	0.468	0.260	0.754	1.572
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	-2.745	-0.347	1.330	-0.347	-0.992	-0.347	1.810	0.754	0.601	0.754	-1.866
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP	1.718	3.157	0.451	0.451	-1.807	-0.354	-1.211	-1.211	-0.776	0.451	-0.463
RICKMAN_HEAD_AND_NECK_CANCER_E RICKMAN_HEAD_AND_NECK_CANCER_E	-0.505	-1.029	-1.933	-1.029	0.782	-0.731	-0.731	1.943	0.404	1.943	0.788
RIZ_ERYTHROID_DIFFERENTIATION RIZ_ERYTHROID_DIFFERENTIATION	-0.911	-0.911	0.484	1.176	-1.280	-0.427	2.179	1.477	-0.633	0.484	-1.764
BOSCO_TH1_CYTOTOXIC_MODULE BOSCO_TH1_CYTOTOXIC_MODULE	0.467	-0.393	-2.225	-2.225	-0.272	-0.756	-0.272	0.333	0.628	2.157	1.553
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	0.675	1.964	2.868	0.301	-1.424	-0.409	-0.409	-0.301	-0.543	-0.707	-2.132
WHITEFORD_PEDIATRIC_CANCER_MARKERS WHITEFORD_PEDIATRIC_CANCER_MARKERS	-1.408	-0.301	2.037	1.447	-1.815	-0.598	0.577	0.959	0.426	-0.301	-1.806
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	-0.634	-0.869	-0.869	0.576	-1.540	-1.167	0.576	0.762	2.114	2.114	-0.863
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	-0.262	0.344	0.481	0.837	-1.310	-0.262	2.547	-0.262	0.344	-0.381	-3.588
LI_WILMS_TUMOR_ANAPLASTIC_UP LI_WILMS_TUMOR_ANAPLASTIC_UP	-0.704	-0.272	0.332	1.206	-0.272	-0.704	-0.704	1.821	-0.704	1.206	-0.702
LAIHO_COLORECTAL_CANCER_SERRATED_DN LAIHO_COLORECTAL_CANCER_SERRATED_DN	-0.711	3.203	-0.326	0.278	-1.392	0.806	0.595	-0.326	0.278	0.278	-2.575
KARLSSON_TGFB1_TARGETS_DN KARLSSON_TGFB1_TARGETS_DN	-1.278	-1.045	0.926	-0.528	-1.549	-1.278	1.510	0.496	1.738	1.510	-0.666
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	-1.580	0.598	1.387	-0.775	-1.117	-1.117	0.824	1.087	-1.117	1.724	-0.338
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	-0.369	0.496	-0.971	-2.163	0.664	0.355	-1.676	-0.522	-0.253	1.333	2.607
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	-2.026	-0.533	0.818	0.818	-2.026	-0.405	1.891	1.639	0.301	0.301	-1.091
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	-0.961	-1.999	-0.422	-0.264	-0.647	-0.647	-0.264	-0.422	1.297	3.353	0.742
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	0.434	2.211	1.488	-0.199	-0.580	-0.580	0.434	-0.580	-0.580	-0.580	-0.578
VANTVEER_BREAST_CANCER_METASTASIS_DN VANTVEER_BREAST_CANCER_METASTASIS_DN	-1.214	-0.334	0.392	0.928	-2.671	-1.214	0.928	0.721	0.928	1.426	-0.903
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	-0.264	1.610	2.092	-0.458	-1.654	-1.373	0.341	-2.342	0.341	0.559	0.700
MEBARKI_HCC_PROGENITOR_WNT_UP MEBARKI_HCC_PROGENITOR_WNT_UP	0.367	-1.591	-0.427	-0.873	-0.326	-1.078	-0.551	-1.078	1.926	1.065	2.759
DASU_IL6_SIGNALING_SCAR_DN DASU_IL6_SIGNALING_SCAR_DN	-0.663	0.362	-0.247	-0.663	-0.663	-0.247	-0.663	-0.663	1.939	1.939	0.364
